Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
Merck (MSD)
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Keytruda
(pembrolizumab) / Merck (MSD)
Zolinza
(vorinostat) / Merck (MSD)
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Decadron
(dexamethasone) / Merck (MSD)
Intron A
(interferon α-2b) / Merck (MSD), Biogen
adavosertib
(AZD1775) / AstraZeneca
MK-2206
/ Merck (MSD)
fosaprepitant
/ Generic mfg.
glucopyranosyl lipid A
(G100) / Merck (MSD)
robatumumab
(SCH 717454) / Merck (MSD)
tivantinib
(ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)